Cytokinin

Structure and Types

• Structurally, cytokinins are derivatives of adenine.
• Natural types include zeatin (named after Zea mays, corn, where it was first isolated), kinetin, and isopentenyladenine (iP).
• Synthetic cytokinins (e.g., 6-benzylaminopurine/BAP, thidiazuron) are widely used in tissue culture and horticulture.

Where They're Made and How They Move

• Primarily synthesized in the root tips (root apical meristem), and also in developing seeds, fruits, and young leaves.
• Transported upward via the xylem to shoots, leaves, and fruits.

Functions

1. Cell division - stimulate mitosis in meristematic tissue; central to the plant cell cycle.
2. Cell differentiation - work with auxin to control organogenesis. The classic principle from tissue culture: high cytokinin:auxin ratio promotes shoot formation, while high auxin:cytokinin ratio promotes root formation.
3. Delay of senescence - inhibit leaf yellowing and aging (the "Richmond-Lansing effect"); cytokinin-treated detached leaves stay green longer.
4. **Apical dominance and ax

Cytokines and Their Role in Immunity

What They Are

Major Families

• Interleukins (ILs) - a large group mediating communication between leukocytes (e.g., IL-1, IL-2, IL-6, IL-17)
• Interferons (IFNs) - type I (IFN-α/β, antiviral) and type II (IFN-γ, activates macrophages and promotes Th1 responses)
• Tumor necrosis factor (TNF) family - drives inflammation and can trigger apoptosis
• Chemokines - a specialized subfamily that directs leukocyte migration/trafficking to sites of infection or injury
• Colony-stimulating factors and growth factors - regulate hematopoiesis

Role in Innate Immunity

• Induce local inflammation (vasodilation, increased vascular permeability, recruitment of neutrophils and monocytes)
• Trigger the acute-phase response in the liver (fever, CRP production)
• Establish an early antiviral state via type I interferons (Jawetz, Melnick & Adelberg's Medical Microbiology, p. 4584-4586; Janeway's Immunobiology, p. 141-159)

Role in Adaptive Immunity

• CD4+ helper T cells are the principal regulators of adaptive immunity, differentiating into subsets (Th1, Th2, Th17, Treg) largely determined by the cytokine milieu present during activation, and each subset in turn produces a characteristic cytokine profile that governs the type of immune response mounted (Rheumatology, 2-Vol Set, p. 7495-7497):
  • Th1 (driven by IL-12, IFN-γ) - cell-mediated immunity against intracellular pathogens, macrophage activation
  • Th2 (driven by IL-4) - humoral immunity, antibody class switching, defense against helminths
  • Th17 (driven by IL-6, IL-23, TGF-β) - defense against extracellular bacteria/fungi, mucosal immunity
  • Treg (IL-10, TGF-β) - immune tolerance and suppression of excessive responses
• Cytokines also drive B-cell proliferation, antibody isotype switching, and cytotoxic T-cell/NK-cell activation (Kaplan & Sadock's Comprehensive Textbook of Psychiatry, p. 337-340; Cellular and Molecular Immunology, p. 512-518)

Clinical Relevance

• Cytokine storm - dysregulated, excessive cytokine release (IL-6, TNF-α, IL-1) causing systemic inflammation, hypotension, and organ failure - seen in sepsis, CAR-T therapy, and severe viral infections.
• Therapeutics: recombinant cytokines (e.g., IFN-α for hepatitis, IL-2 for renal cell carcinoma) and cytokine blockers (anti-TNF agents, IL-6 receptor antagonists like tocilizumab, IL-17 inhibitors) are used across autoimmune disease, cancer, and inflammatory conditions.
• Immunocytokines (cytokines fused to antibodies to target them to tumors) are an active area of cancer immunotherapy research - a 2025 systematic review found this remains a promising but still-maturing therapeutic approach (PMID: 40554920).
• Circulating cytokine levels are also being explored as drug targets for immune-related diseases via genomic/Mendelian randomization approaches (PMID: 39794498).